Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × B-cell Malignancies × Clarithromycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 6 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 4 Stomach Neoplasms 3 Dyspepsia 2 Recurrence 1 Peptic Ulcer 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Gastritis 1 B-cell Malignancies 1

Interventions

zanubrutinib 2 Voriconazole 1 Fluconazole 1 Diltiazem 1 Clarithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04551963 2024-10-26

Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies

BeiGene

Phase 1 Completed

26 enrolled 20 charts

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡